Barclays’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Hold
2
﹤0.01% 4377
2025
Q1
$0 Buy
+2
New ﹤0.01% 4400
2022
Q2
Sell
-10,528
Closed -$28K 4742
2022
Q1
$28K Sell
10,528
-68,202
-87% -$181K ﹤0.01% 4212
2021
Q4
$341K Sell
78,730
-32,123
-29% -$139K ﹤0.01% 2667
2021
Q3
$564K Sell
110,853
-15,928
-13% -$81K ﹤0.01% 2550
2021
Q2
$802K Sell
126,781
-10,523
-8% -$66.6K ﹤0.01% 2240
2021
Q1
$1.06M Buy
137,304
+47,290
+53% +$366K ﹤0.01% 2268
2020
Q4
$589K Buy
90,014
+60,474
+205% +$396K ﹤0.01% 2251
2020
Q3
$197K Sell
29,540
-5,122
-15% -$34.2K ﹤0.01% 2748
2020
Q2
$289K Buy
34,662
+11,295
+48% +$94.2K ﹤0.01% 2624
2020
Q1
$179K Sell
23,367
-30,926
-57% -$237K ﹤0.01% 2595
2019
Q4
$452K Buy
54,293
+27,774
+105% +$231K ﹤0.01% 2745
2019
Q3
$196K Sell
26,519
-8,809
-25% -$65.1K ﹤0.01% 3066
2019
Q2
$397K Sell
35,328
-5,054
-13% -$56.8K ﹤0.01% 2853
2019
Q1
$434K Buy
40,382
+38,682
+2,275% +$416K ﹤0.01% 2694
2018
Q4
$26K Sell
1,700
-15,622
-90% -$239K ﹤0.01% 3319
2018
Q3
$321K Sell
17,322
-667
-4% -$12.4K ﹤0.01% 2844
2018
Q2
$411K Buy
17,989
+1,957
+12% +$44.7K ﹤0.01% 2390
2018
Q1
$457K Sell
16,032
-4,838
-23% -$138K ﹤0.01% 2348
2017
Q4
$441K Sell
20,870
-6,516
-24% -$138K ﹤0.01% 2182
2017
Q3
$497K Buy
27,386
+18,235
+199% +$331K ﹤0.01% 1919
2017
Q2
$142K Sell
9,151
-3,669
-29% -$56.9K ﹤0.01% 2609
2017
Q1
$221K Buy
12,820
+12,591
+5,498% +$217K ﹤0.01% 2432
2016
Q4
$3K Sell
229
-120
-34% -$1.57K ﹤0.01% 3518
2016
Q3
$5K Buy
+349
New +$5K ﹤0.01% 3405
2016
Q1
Sell
-167
Closed -$3K 3469
2015
Q4
$3K Buy
+167
New +$3K ﹤0.01% 2974